Crowdonomics
MedicaMetrix, Inc/DE

Reg A+ · Equity · Sep 2021

ClosedReg A+Equity
via DALMORE GROUP LLC · last checked Aug 16, 2026
Raised
$0 / $20M max
0% of ceiling
Investors
—
—
Estimated pre-money
$68.6M
—

Financials disclosed in this offering

FY2020 · hover for source
$0
−$1.0M
FY2020
RevenueNet income
Metric
FY2020 audited
Income statement
Revenue
$0
Cost of goods sold
$1,017,987
Net income
-$1,017,987
Balance sheet
Cash
$256,210
Accounts receivable
$88,000
Total assets
$352,725
Long-term debt
$0
Total liabilities
$424,699
Other
Headcount
13

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

2 amendments
  1. Oct 19, 2021
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  2. Oct 7, 2021
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$68.6M
Price / share$5.00
Shares offered4,000,000

Estimated, not stated: $5.00 × 13,727,723 securities outstanding.

Offering details

Target—
Max$20,000,000
Min investment—
OpenedSep 14, 2021
Deadline—
Days active1,852

Links & provenance

Source: SEC EDGAR
0001493152-21-022601
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.